CVM

CEL-SCI Corp

2.280

-0.790-25.73%

After Hours: 2.310 +0.030 +1.31%19:59 05/01 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.835/3.070

TODAY RANGE2.250-2.900

VOL803.78K

MARKET CAP19.28M

52 WEEK RANGE1.980-13.48

AVG VOL (3M)64.13K

% TURNOVER9.50%

TURNOVER--

P/E (TTM)-0.4351

% RANGE20.85%

EPS(TTM)-5.2407

P/E(FORWARD)-0.5481

P/B1.723

BVPS1.323

DIVIDEND--

P/S159.87

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP17.71M

SHARES OUTSTANDING8.46M

NEXT EARNINGS05/12-05/18

FREE FLOAT7.77M

LOT SIZE1

EX-DATE05/20/2025

News

Press Releases

Financial Reports

Profile

Dow Jones·04/17 22:03
*CEL-SCI to Offer Up to 3.44M Shrs
Seeking Alpha·02/18 20:44
Cel-Sci GAAP EPS of -$0.68
Dow Jones·02/18 14:01
*CEL-SCI 1Q Loss/Shr 68c Vs. EPS $3.25 >CVM
Dow Jones·02/18 14:01
*CEL-SCI Reports Fiscal 1Q 2026 Results
Dow Jones·02/18 14:00
Press Release: CEL-SCI Reports Fiscal First Quarter 2026 Results
TipRanks·01/27 02:01
Top Executive Makes Bold Move With Fresh Cel-Sci Stock Buy
NASDAQ·01/26 19:09
Monday 1/26 Insider Buying Report: BDSX, CVM
TipRanks·01/20 13:37
One new option listing and option delistings on January 20th
Seeking Alpha·12/30/2025 04:34
Cel-Sci reports FY results
Dow Jones·12/29/2025 14:00
*CEL-SCI Plans to Seek Early Approval in U.S. Based on Pre-Surgical Response Rate Upon Full Enrollment >CVM
Dow Jones·12/29/2025 14:00
Press Release: CEL-SCI Reports Fiscal 2025 Results
TipRanks·12/06/2025 02:07
Cel-Sci CEO Makes Bold Stock Purchase!
TipRanks·11/07/2025 21:35
CEL-SCI files to sell 375,000 shares of common stock for holders
TipRanks·11/05/2025 22:33
Cel-Sci Extends Shareholder Rights Agreement to 2030
NASDAQ·09/19/2025 04:47
After-Hours Trading Sees Sharp Gains Across Emerging Growth Names

Same Industry

Name/Symbol

Change%

Price

CVM

Regeneron Pharmaceuticals

REGN

-1.89%

751.57

GridAI Tech

GRDX

0.00%

2.270

BIONTECH

BNTX

-0.09%

105.46

United Therapeutics Corp.

UTHR

+0.13%

572.10

Vertex Pharmaceuticals Inc

VRTX

-1.11%

430.29

SIGA

Moderna

MRNA

-3.31%

45.58

Charles Riv Labs Intl Inc

CRL

-2.34%

167.23

Medpace Holdings

MEDP

+4.35%

410.54

Talphera Inc

TLPH

-3.00%

0.7750

ICON PLC

ICLR

-3.92%

102.17

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-2.97%

158.98

MOLECULAR PARTNERS AG

MOLN

+1.36%

4.460

Arcturus Therape

ARCT

+1.42%

8.59

Gilead Sciences Inc

GILD

-2.42%

130.40

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

-0.86%

94.65

APVO

Biospecifics

BSTC

0.00%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.